Toward Targeted Therapeutics: An Examination of the Policy Landscape for Personalized Medicine
May 25, 2016
National Press Club
Event Website: Click here to register
Registration is free for PMC members, government representatives and members of the press. Non-members are welcome to attend for $100.
The Annual State of Personalized Medicine Luncheon Address provides provides a forum for PMC members and guests from the health care community to engage policy leaders in a discussion of the key issues facing the field.
This year's keynote speaker, Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl, will deliver remarks and take questions on the value and promise of personalized medicine.
Last year more than a quarter of the U.S. Food and Drug Administration's new drug approvals were personalized medicines, and 42 percent of drugs currently in development are associated with a biomarker strategy. We hope you will join us to discuss the policies required to advance the field.